Keywords:
Neoplasia, Metastases, Audit and standards, Outcomes analysis, Ultrasound, Oncology, Breast
Authors:
J. H. del Riego Ferrari1, M. J. Díaz Ruiz2, M. Teixidó Vives3, M. Vilagran Fraguell4, L. Canales Aliaga5, J. Ribé Pie6, M. Sentís Crivellé1; 1Sabadell/ES, 2Manresa/ES, 3Terrassa (Barcelona)/ES, 4Granollers/ES, 5Terrassa/ES, 6Vic/ES
DOI:
10.1594/seram2014/S-0808
Bibliografía
1.
Giuliano AE,
McCall L,
Beitsch P,
Whitworth P,
Blumencranz P,
Leitch AM,
et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
Ann Surg 2010;252(3):426e32 [discussion 432e433].
2.
Giuliano AE,
Hunt KK,
Ballman KV,
Beitsch P,
Whitworth P,
Blumencranz P, et al.
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
J Am Med Ass 2011;305(6):569e75.
3.
Bedi DG,
Krishnamurthy R,
Krishnamurthy S,
et al.
Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study.
AJR Am J Roentgenol 2008;191(3):646–52.
4.
S.
Diepstraten,
et al. Value of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Preventing Completion Axillary Lymph Node Dissection in Breast Cancer: A Systematic Review and Meta-Analysis.
Ann Surg Oncol 2014; 21(1):51-9.